Search

everythinglearnresearchcommunity

for

Search:↓

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

Androgens cause oil-producing skin cells with androgen receptors to mature and produce more oil.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Androstenedione is better than testosterone for diagnosing PCOS in Indian women.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

PCOS is diagnosed when at least two of these three features are present: polycystic ovaries, irregular ovulation, and high androgen levels.

Doctors used a special blood sampling technique to diagnose a woman's rare ovarian tumor that was producing male hormones.

Hormone levels in hair vary across the head, with the highest concentration of a key hormone linked to hair loss at the top.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

All women with Polycystic Ovary Syndrome (PCOS) in a study had at least one skin disorder, with the most common being excessive hair growth, acne, dark skin patches, hair loss, and oily skin.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

The Free Androgen Index (FAI) is the best indicator of early hair loss in men before age 30.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

The body's change of testosterone into DHT is not necessary for testosterone's muscle and sexual effects.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

Men with male-pattern baldness have more androgen receptors in their scalp's oil glands, which may contribute to hair loss.

Some women with acne have higher levels of free testosterone, which might suggest using hormonal treatments for acne.

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.

Male hormones cause different growth in identical human hair follicles due to their unique epigenetic characteristics.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

BRL 7660, once studied for male contraception, showed promise as an acne treatment but was not developed further due to competing drugs.

Men with early balding should be checked for metabolic syndrome, as there's a link between the two.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

Women with acne and irregular periods had higher active testosterone levels, which could suggest the usefulness of antiandrogen treatment.

Mouse genital development depends on male or female hormones for specific features.